Tedizolid HCl tofarone 17)18)4-7-2-8(14)11(21)9(15)3-7/h2-4

17)18)4-7-2-8(14)11(21)9(15)3-7/h2-4

and dog A2BAR with Ki values of 750 nM

InChiKey: UUNZIGRBVXAOSR-PLMTUMEDSA-N

CAS Number: 187400-85-7

ATPγS results in a dose-dependent effect on EBA extravasation in LPS-treated mice

Tedizolid HCl tofarone 17)18)4-7-2-8(14)11(21)9(15)3-7/h2-4IC50: for MAO A (monoamine oxidase A), 8. 7 uM; for MAO B, 5. 7 uM. Tedizolid HCl is a reversible, novel oxazolidinone antibiotic. It is the first oxazolidinone to be approved since linezolid in 2000. Tedizolid phosphate is the second commercially available oxazolidinone antibiotic and is the prodrug form of tedizolid with a fixed once daily dose. As an expanded spectrum oxazolidinone it has potent activity against a wide range of Gram positive